Specifications tableSubjectBiologySpecific subject areaProteomicsType of dataLC-MS/MS data and identification dataHow data were acquiredLC-MS analysis is performed with an Ultimate 3000 Nano LC System (Thermo Fisher Scientific) coupled to a Q Exactive HF benchtop Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray source (Thermo Fisher Scientific).Data formatRaw and analyzed dataParameters for data collectionShotgun proteomes for *M. hominis* cells growing in two conditions of culturing.Description of data collection*M. hominis* cells growing in culture with arginine or thymidine as carbon source at log phase were collected, and their total proteomes were analyzed by shotgun proteomics in three biological replicates.Data source locationResearch and Clinical Center of Physical-Chemical Medicine, Moscow, Russian FederationData accessibilityData were deposited to the PRIDE repository:\
Project accession: PXD018714 Project <https://www.ebi.ac.uk/pride/archive/projects/PXD018714>

Value of the data {#sec0001a}
=================

•This dataset provides proteome data for *M. hominis* cells growing in culture with arginine or thymidine as carbon source.•These data can be interesting for the investigation of interaction with the environment of opportunistic bacteria *M. hominis*.•These data can be interesting for the investigation of metabolism of *M. hominis* and another mycoplasma species that can be a model of a minimal cell.

1. Data description {#sec0001}
===================

*Mycoplasma hominis* is a human opportunistic bacterium that can cause acute and chronic infections of the urogenital tract [@bib0001]. Like all other Mycoplasma species, it is characterized by the reduced genome size (about 550 ORFs), and, consequently, reduction of the main metabolic pathways. *M. hominis* cells cannot effectively use glucose as a carbon and energy source. Therefore, the main pathway of energy metabolism is the arginine dihydrolase pathway, which includes arginine deiminase, ornithine carbamoyltransferase and carbamate kinase [@bib0002]. However, *M. hominis* cells can utilize nucleosides. In thymidine catabolic pathway the thymidine phosphorylase, phosphopentose mutase and deoxyribose-phosphate aldolase are involved [@bib0003].

We performed shotgun proteome analysis of *M. hominis* cells in liquid medium with arginine or thymidine as a carbon and energy source. LC-MS analysis was performed with an Ultimate 3000 Nano LC System (Thermo Fisher Scientific) coupled to a Q Exactive HF benchtop Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray source (Thermo Fisher Scientific). Protein identification and label-free quantification were made by PEAKS software. The data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the identifier PXD018714.

Totally, 466 proteins were identified in both cases of *M. hominis* culturing with arginine or thymidine as carbon source (table S1). Obtained datasets show good reproducibility between biological replicas as demonstrated by the heatmap ([Fig. 1](#fig0001){ref-type="fig"}). Range of differences in the protein changes is shown on volcano plot ([Fig. 2](#fig0002){ref-type="fig"}). Proteins, significantly changed between aforementioned conditions (fold change \> 1.5, *t*-test with Benjamini--Hochberg correction, *p* \< 0.05), are presented in [Table 1](#tbl0001){ref-type="table"}. All the above-mentioned enzymes from the metabolic pathways of arginine and thymidine utilization have been identified. When growing on thymidine, the only thymidine phosphorylase abundance was increased by 1.8 times, the abundance of other enzymes did not significantly change.Fig. 1Similarity of proteomic data between samples.Fig 1Fig. 2Different protein abundance for M. hominis growing with thymidine to growing with arginine.Fig 2Table 1Significantly changed proteins for *M. hominis* growing in different growth conditions. Log2FC -- logarithm of fold change ratio for growth with thymidine to growth with arginine.Table 1AccessionLog2FCP value adj.DescriptionWP_012855601.11.770.010hypothetical proteinWP_012855692.11.710.021pyruvate kinaseWP_012855537.11.560.013hypothetical proteinWP_012855507.11.470.010transcriptional regulator MraZWP_012855710.11.440.006ABC transporter ATP-binding proteinWP_012855796.11.270.01430S ribosome-binding factor RbfAWP_012855529.11.110.005N(G) N(G)-dimethylarginine dimethylaminohydrolaseWP_012855730.11.060.029tRNA uridine-5-carboxymethylaminomethyl(34) synthesis GTPase MnmEWP_012855297.11.050.038chaperone protein ClpBWP_012855435.10.990.048hypothetical proteinWP_012855457.10.920.008NAD(+) synthaseWP_012855371.10.880.033hypothetical proteinWP_012855709.10.880.008hypothetical proteinWP_012855608.10.840.008thymidine phosphorylaseWP_012855370.10.830.037NUDIX domain-containing proteinWP_012855640.10.800.005DUF885 domain-containing proteinWP_012855422.10.780.02630S ribosomal protein S12WP_012855390.10.740.048single-stranded DNA-binding proteinWP_012855783.10.740.021type I glyceraldehyde-3-phosphate dehydrogenaseWP_012855759.10.670.032serine/threonine-protein phosphataseWP_012855649.10.640.010protein LemAWP_012855632.10.640.008lactate dehydrogenaseWP_012855504.10.630.008cell division protein FtsZWP_012855582.1−0.610.033leucine--tRNA ligaseWP_012855330.1−0.610.009Lmp1 proteinWP_012855717.1−0.620.036GTPase EraWP_012855408.1−0.620.008alanine--tRNA ligaseWP_012855532.1−0.630.037XRE family transcriptional regulatorWP_012855641.1−0.630.010oligoendopeptidase FWP_012855592.1−0.640.008hypothetical proteinWP_012855418.1−0.650.018RluA family pseudouridine synthaseWP_012855433.1−0.650.035rRNA pseudouridine synthaseWP_012855356.1−0.670.021hypothetical proteinWP_012855477.1−0.690.023NAD-dependent DNA ligase LigAWP_012855316.1−0.700.0221-acyl-sn-glycerol-3-phosphate acyltransferaseWP_012855626.1−0.700.022ABC transporter ATP-binding proteinWP_012855757.1−0.700.04816S rRNA (guanine(966)-N(2))-methyltransferase RsmDWP_012855399.1−0.710.024TlyA family rRNA (cytidine-2′-O)-methyltransferaseWP_012855628.1−0.720.00816S rRNA (guanine(527)-N(7))-methyltransferase RsmGWP_012855539.1−0.720.040DegV family EDD domain-containing proteinWP_012855668.1−0.730.021YihA family ribosome biogenesis GTP-binding proteinWP_012855402.1−0.730.003DNA polymerase IVWP_012855542.1−0.730.048DNA-directed RNA polymerase subunit beta\'WP_012855470.1−0.730.026deoxyguanosine kinaseWP_012855471.1−0.730.021hypoxanthine phosphoribosyltransferaseWP_020002555.1−0.740.021DUF402 domain-containing proteinWP_012855437.1−0.740.023peptide chain release factor 1WP_041359585.1−0.760.011hypothetical proteinWP_012855413.1−0.770.037tRNA1(Val) (adenine(37)-N6)-methyltransferaseWP_012855453.1−0.770.016alcohol dehydrogenaseWP_012855553.1−0.780.008type I methionyl aminopeptidaseWP_012855662.1−0.810.008RpiB/LacA/LacB family sugar-phosphate isomeraseWP_012855625.1−0.810.037hypothetical proteinWP_012855642.1−0.820.037adenine phosphoribosyltransferaseWP_080569061.1−0.820.026hypothetical proteinWP_012855743.1−0.850.024ribonuclease IIIWP_012855497.1−0.850.004ribosome biogenesis GTPase YlqFWP_012855518.1−0.850.035hypothetical proteinWP_012855403.1−0.850.010nicotinate (nicotinamide) nucleotide adenylyltransferaseWP_012855376.1−0.860.008DNA polymerase III subunitWP_012855694.1−0.860.003exodeoxyribonuclease V subunit alphaWP_012855699.1−0.870.010tRNA (guanosine(46)-N7)-methyltransferase TrmBWP_012855514.1−0.880.032RNA methyltransferaseWP_012855721.1−0.910.026spermidine/putrescine ABC transporter permeaseWP_012855655.1−0.920.0172 3-bisphosphoglycerate-independent phosphoglycerate mutaseWP_012855740.1−0.940.033hypothetical proteinWP_012855290.1−0.940.028TatD family deoxyribonucleaseWP_012855419.1−0.960.011hypothetical proteinWP_012855591.1−0.960.028hypothetical proteinWP_012855323.1−0.980.010hypothetical proteinWP_012855798.1−0.990.02323S rRNA (pseudouridine(1915)-N(3))-methyltransferase RlmHWP_012855725.1−0.990.011RDD family proteinWP_080569060.1−0.990.015hypothetical proteinWP_012855552.1−1.000.019translation initiation factor IF-1WP_012855289.1−1.020.018ribosomal RNA small subunit methyltransferase AWP_012855634.1−1.020.044hypothetical proteinWP_012855765.1−1.050.028hypothetical proteinWP_012855334.1−1.080.026hypothetical proteinWP_012855502.1−1.090.00816S rRNA (uracil(1498)-N(3))-methyltransferaseWP_012855595.1−1.110.010putative immunoglobulin-blocking virulence proteinWP_041359577.1−1.110.024hypothetical proteinWP_012855512.1−1.130.017tRNA pseudouridine(55) synthase TruBWP_012855378.1−1.260.02330S ribosomal protein S20WP_012855580.1−1.300.021signal peptidase IIWP_012855576.1−1.330.023hypothetical proteinWP_012855409.1−1.360.033Holliday junction resolvase RuvXWP_012855438.1−1.530.023peptide chain release factor N(5)-glutamine methyltransferaseWP_012855523.1−1.690.008hypothetical proteinWP_012855355.1−1.740.037hypothetical proteinWP_012855495.1−1.890.001signal recognition particle proteinWP_012855794.1−2.050.011DUF448 domain-containing proteinWP_012855696.1−2.490.017tRNA lysidine(34) synthetase TilSWP_012855645.1−2.550.005hypothetical proteinWP_012855350.1−3.490.017hypothetical protein

2. Experimental design, materials, and methods {#sec0002}
==============================================

2.1. Cell cultivation {#sec0003}
---------------------

*M. hominis* H34 strain was grown on Brain Heart Infusion (DIFCO, USA) supplemented with 10% horse serum (Biolot, Russia), 1% yeast extract (Helicon, Russia), penicillin (Sintez, Russia) with a final concentration 500 units/ml with the addition of 1% arginine or thymidine as a carbon source. The culture was grown at 37 °C till log-phase for 48 h with arginine or 96 h with thymidine carbon source.

2.2. Protein extraction {#sec0004}
-----------------------

Aliquots (10 ml) of log-phase growing cells of *M. hominis H34* were collected by centrifugation at 12,000 g at 4 °C for 10 min. Then cells were washed twice by addition of 1 ml cold PBS buffer and centrifugation at 12,000 g at 4 °C for 10 min, 10 μl of 10% sodium deoxycholate (DCNa) and 0.5 μl nuclease mix (GE Healthcare, USA) was added to the cell pellet. After incubation for 1 hour at 4 °C, the sample was resuspended in 100 µl 100 mM Tris-HCl buffer (pH 8.0) containing 0.1% DCNa, 8 M urea and 2.5 mM EDTA. After incubation for 20 min the sample was centrifuged at 16,000 g for 10 min at 4 °C to remove intact cells and debris. The supernatant was collected, and protein concentration was measured using BCA Assay Kit (Sigma-Aldrich, USA).

2.3. Protein preparation to shotgun proteomic {#sec0005}
---------------------------------------------

Disulfide bonds were reduced in supernatant (containing 200 μg of total protein) by the addition of Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (Sigma-Aldrich, USA) to a final concentration of 5 mM and reaction was incubated for 60 min at 37 °C. To alkylate free cysteines, chloroacetamide (Sigma-Aldrich, USA) was added to a final concentration of 30 mM and placed at room temperature in the dark for 30 min. The step of adding TCEP was repeated. Then the sample was diluted 6-fold with 50 mM Tris-HCl, pH 8.0 with 0.01% DCNa. Trypsin Gold (Promega, USA) was added for a final trypsin:protein ratio of 1:50 (w/w) and incubated at 37 °C overnight. To stop trypsinolysis and degrade the acid-labile DCNa, trifluoroacetic acid (TFA) was added to the final concentration of 0.5% (v/v) (the pH should be less than 2.0), incubated at 37 °C for 45 min and the samples were centrifuged at 14,000 g for 10 min to remove the DCNa. Peptide extract was desalted using a Discovery DSC-18 Tube (Supelco, USA) according to the manufacturer protocol. Peptides were eluted with 1 ml of 75% acetonitrile in water containing 0.1% TFA, dried in an Acid-Resistant CentriVap Benchtop Vacuum concentrator (Labconco, USA) and resuspended in 3% acetonitrile in water containing 0.1% TFA to the final concentration of 5 μg/μl.

2.4. LC-MS analysis {#sec0006}
-------------------

LC-MS analysis was carried out on an Ultimate 3000 RSLC nano HPLC system connected to a QExactive Plus mass spectrometer (Thermo Fisher Scientific, USA). Samples were loaded to a home-made trap column 20×0.1 mm, packed with Inertsil ODS3 3 μm sorbent (GL Sciences, Japan), in the loading buffer (2% ACN, 98% H~2~O, 0.1% TFA) at 10 μl/min flow and separated at RT in a home-packed fused-silica column 500×0.1 mm packed with Reprosil PUR C18AQ 1.9 (Dr. Maisch, Germany) into the emitter prepared with P2000 Laser Puller (Sutter, USA) [@bib0004]. Samples were eluted with a linear gradient of 80% ACN, 19.9% H~2~O, 0.1% FA (buffer B) in 99.9% H~2~O, 0.1% FA (solvent A) from 4 to 36% of solvent B in 1 h at 0.44 μl/min flow at RT.

MS data were collected in DDA mode. MS1 parameters were as follows: 70 K resolution, 350--2000 scan range, max injection time 50 ms, AGC target 3 × 10^6^. Ions were isolated with 1.4 m/z window and 0.2 m/z offset targeting 10 highest intensity peaks of +2 to +6 charge, 8 × 10^3^ minimum AGC, preferred peptide match and isotope exclusion. Dynamic exclusion was set to 40 s. MS2 fragmentation was carried out in HCD mode at 17,5 K resolution with 27% NCE. Ions were accumulated for max 45 ms with target AGC 1 × 10^5^.

2.5. Protein identification and quantitative analysis {#sec0007}
-----------------------------------------------------

Identification and label-free quantification analysis were performed with PEAKS software [@bib0005] with default settings. The data were searched against *M. hominis* ATCC 23,114 NCBI database and have been deposited to the ProteomeXchange Consortium via the PRIDE [@bib0006] partner repository with the dataset identifier PXD018714 and project 10.6019/PXD018714 (<http://dx.doi.org/10.6019/PXD018714>, <https://www.ebi.ac.uk/pride/archive/projects/PXD018714>). Further calculations and visualizations were made in R [@bib0007].
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